Deals
23andMe in Talks to Go Public Via Branson SPAC
- VG Acquisition deal could value DNA firm at about $4 billion
- 23andMe, led by Anne Wojcicki, had $2.5 billion value in 2020
23andMe DNA genetic testing kit
Photographer: Cayce Clifford/BloombergThis article is for subscribers only.
Consumer DNA-testing company 23andMe Inc. is in talks to go public through a roughly $4 billion deal with VG Acquisition Corp., a special purpose acquisition company founded by billionaire Richard Branson, according to people familiar with the matter.
A deal could be announced in the coming weeks if talks are successful, said the people, who asked not to be identified because the information was private. Discussions could still fall apart, the people said.